CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 19 enrolled
Drug / intervention
Vitamin D +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01354964
NCT01354964Phase 2Completed
CompareCT.gov

Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation

Albert Einstein College of Medicine·interventional·Posted May 17, 2011·Updated Nov 2, 2020

In Brief

A Phase 2 clinical trial evaluating Vitamin D and Placebo for Insulin Resistance. Completed, enrolled 19 participants across 1 site.

Detailed Summary

The purpose of this research is to study the effects of Vitamin D supplementation on the body's response to insulin (a hormone that controls blood sugar), on inflammation, and on specific cells and processes in fat tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsulin Resistance
CountriesUnited States
CollaboratorsNational Center for Research Resources (NCRR)

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 17, 2011
Enrollment StartMar 13, 2009
Primary CompletionJun 3, 2015
Study CompletionSep 3, 2015
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 15.1 years ago

Interventions

Vitamin Ddrug

Placebodrug